Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

98.35
Delayed Data
As of Aug 28
 -0.29 / -0.29%
Today’s Change
84.17
Today|||52-Week Range
106.84
+6.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line9.2B9.6B9.3B10.6B
 
 
 
 
 
Depreciation4.8B4.6B4.7B4.3B
 
 
 
 
 
Total Other Cash Flow420.8M118.0M-161.9M-559.4M
 
 
 
 
 
Funds From Operations14.4B14.3B13.9B14.4B
 
 
 
 
 
Funds From/For Other Operating Expenses112.9M140.0M738.5M617.8M
 
 
 
 
 
Net Cash Flow - Operating Activities14.3B14.2B13.1B13.7B
 
 
 
 
 
 
InvestingIncrease In Investments-1.9B-1.8B-442.7M-403.3M
 
 
 
 
 
Decrease In Investments3.4B737.2M563.6M3.8B
 
 
 
 
 
Capital Expenditures-2.2B-2.7B-3.1B-2.6B
 
 
 
 
 
Fixed Asset Disposal61.0M92.0M60.0M59.3M
 
 
 
 
 
Net Assets From Acquisitions -568.7M-1.7B-42.0M-327.2M
 
 
 
 
 
Other Investing - Uses-48.0M-57.0M-39.0M-59.3M
 
 
 
 
 
Other Investing - Sources647.7M181.0M170.9M1.1B
 
 
 
 
 
Net Cash Flow Investing-791.6M-5.7B-3.3B870.8M
 
 
 
 
 
 
FinancingShort Term Borrowings-3.1B-1.7B595.6M-105.8M
 
 
 
 
 
Long Term Borrowings280.9M2.0B92.9M6.0B
 
 
 
 
 
Long Term Debt Reduction-28.0M-704.2M-2.0B-2.6B
 
 
 
 
 
Net Proceeds Stock Sale162.9M414.1M1.7B0.00
 
 
 
 
Common Preferred Redeemed-3.6B-505.1M-2.9B-6.8B
 
 
 
 
 
Common Dividends-5.4B-6.0B-6.1B-6.7B
 
 
 
 
 
Cash Dividends Paid - Total-5.4B-6.0B-6.1B-6.7B
 
 
 
 
 
Other Sources - Financing0.000.004.0M2.4B
 
 
 
Other Uses - Financing3.4B92.0M102.9M138.4M
 
 
 
 
 
Net Cash Flow - Financing-15.0B-6.7B-8.8B-8.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-103.0M-1.0M81.9M-291.6M
 
 
 
 
 
 
Net Change In Cash-1.5B1.8B1.1B6.6B